These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22436610)

  • 21. Endocytosis and intracellular trafficking of ErbBs.
    Sorkin A; Goh LK
    Exp Cell Res; 2008 Oct; 314(17):3093-106. PubMed ID: 18793634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2, and ErbB3, in human ocular surface epithelia.
    Liu Z; Carvajal M; Carraway CA; Carraway K; Pflugfelder SC
    Cornea; 2001 Jan; 20(1):81-5. PubMed ID: 11189010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pertuzumab increases epidermal growth factor receptor down-regulation by counteracting epidermal growth factor receptor-ErbB2 heterodimerization.
    Hughes JB; Berger C; Rødland MS; Hasmann M; Stang E; Madshus IH
    Mol Cancer Ther; 2009 Jul; 8(7):1885-92. PubMed ID: 19584234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinase C regulates ErbB3 turnover.
    Dietrich M; Malik MS; Skeie M; Bertelsen V; Stang E
    Exp Cell Res; 2019 Sep; 382(2):111473. PubMed ID: 31233741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetraspanin CD82 regulates compartmentalisation and ligand-induced dimerization of EGFR.
    Odintsova E; Voortman J; Gilbert E; Berditchevski F
    J Cell Sci; 2003 Nov; 116(Pt 22):4557-66. PubMed ID: 14576349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homo- and Heteroassociations Drive Activation of ErbB3.
    Váradi T; Schneider M; Sevcsik E; Kiesenhofer D; Baumgart F; Batta G; Kovács T; Platzer R; Huppa JB; Szöllősi J; Schütz GJ; Brameshuber M; Nagy P
    Biophys J; 2019 Nov; 117(10):1935-1947. PubMed ID: 31653451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells.
    Grøvdal LM; Kim J; Holst MR; Knudsen SL; Grandal MV; van Deurs B
    Cell Signal; 2012 Jan; 24(1):296-301. PubMed ID: 21951604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated ErbB3 Translocates to the Nucleus via Clathrin-independent Endocytosis, Which Is Associated with Proliferating Cells.
    Reif R; Adawy A; Vartak N; Schröder J; Günther G; Ghallab A; Schmidt M; Schormann W; Hengstler JG
    J Biol Chem; 2016 Feb; 291(8):3837-47. PubMed ID: 26719328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macropinocytosis inhibitors and Arf6 regulate ErbB3 nuclear localization in prostate cancer cells.
    Koumakpayi IH; Le Page C; Delvoye N; Saad F; Mes-Masson AM
    Mol Carcinog; 2011 Nov; 50(11):901-12. PubMed ID: 21438025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2012 Nov; 24(11):1981-8. PubMed ID: 22800866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
    Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ
    Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
    Asp N; Pust S; Sandvig K
    Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer.
    Hickinson DM; Klinowska T; Speake G; Vincent J; Trigwell C; Anderton J; Beck S; Marshall G; Davenport S; Callis R; Mills E; Grosios K; Smith P; Barlaam B; Wilkinson RW; Ogilvie D
    Clin Cancer Res; 2010 Feb; 16(4):1159-69. PubMed ID: 20145185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligomers of ERBB3 have two distinct interfaces that differ in their sensitivity to disruption by heregulin.
    Kani K; Warren CM; Kaddis CS; Loo JA; Landgraf R
    J Biol Chem; 2005 Mar; 280(9):8238-47. PubMed ID: 15611073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody-induced ErbB3 receptor internalization and degradation inhibits growth and migration of human melanoma cells.
    Belleudi F; Marra E; Mazzetta F; Fattore L; Giovagnoli MR; Mancini R; Aurisicchio L; Torrisi MR; Ciliberto G
    Cell Cycle; 2012 Apr; 11(7):1455-67. PubMed ID: 22421160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2.
    Maurer CA; Friess H; Kretschmann B; Zimmermann A; Stauffer A; Baer HU; Korc M; Büchler MW
    Hum Pathol; 1998 Aug; 29(8):771-7. PubMed ID: 9712416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ErbB3 interacts with Hrs and is sorted to lysosomes for degradation.
    Fosdahl AM; Dietrich M; Schink KO; Malik MS; Skeie M; Bertelsen V; Stang E
    Biochim Biophys Acta Mol Cell Res; 2017 Dec; 1864(12):2241-2252. PubMed ID: 28867611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
    Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ErbB receptors mediate both migratory and proliferative activities in human melanocytes and melanoma cells.
    Gordon-Thomson C; Jones J; Mason RS; Moore GP
    Melanoma Res; 2005 Feb; 15(1):21-8. PubMed ID: 15714117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
    Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
    EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.